Follow
Esra Nalbat, PhD
Esra Nalbat, PhD
Verified email at metu.edu.tr - Homepage
Title
Cited by
Cited by
Year
DEEPScreen: high performance drug–target interaction prediction with convolutional neural networks using 2-D structural compound representations
AS Rifaioglu, E Nalbat, V Atalay, MJ Martin, R Cetin-Atalay, T Doğan
Chemical science 11 (9), 2531-2557, 2020
1652020
Synthesis and cellular bioactivities of novel isoxazole derivatives incorporating an arylpiperazine moiety as anticancer agents
B Çalışkan, E Sinoplu, K İbiş, E Akhan Güzelcan, R Çetin Atalay, ...
Journal of enzyme inhibition and medicinal chemistry 33 (1), 1352-1361, 2018
382018
Treatment of breast cancer with autophagy inhibitory microRNAs carried by AGO2-conjugated nanoparticles
O Unal, Y Akkoc, M Kocak, E Nalbat, AI Dogan-Ekici, H Yagci Acar, ...
Journal of nanobiotechnology 18, 1-18, 2020
362020
CROssBAR: comprehensive resource of biomedical relations with knowledge graph representations
T Doğan, H Atas, V Joshi, A Atakan, AS Rifaioglu, E Nalbat, A Nightingale, ...
Nucleic acids research 49 (16), e96-e96, 2021
232021
Synthesis and biological evaluation of novel isoxazole-piperazine hybrids as potential anti-cancer agents with inhibitory effect on liver cancer stem cells
K İbiş, E Nalbat, B Çalışkan, DC Kahraman, R Cetin-Atalay, E Banoglu
European Journal of Medicinal Chemistry 221, 113489, 2021
172021
DEEPScreen: high performance drug–target interaction prediction with convolutional neural networks using 2-D structural compound representations. Chem Sci 11: 2531–2557
AS Rifaioglu, E Nalbat, V Atalay, MJ Martin, R Cetin-Atalay, T Dogan
52020
CROssBAR: comprehensive resource of biomedical relations with deep learning applications and knowledge graph representations
T Doğan, H Atas, V Joshi, A Atakan, AS Rifaioglu, E Nalbat, A Nightingale, ...
bioRxiv, 2020.09. 14.296889, 2020
32020
EXPLOITING MOLECULAR NETWORKS BY REPURPOSED DRUGS AND NOVEL SMALL MOLECULES IN HEPATOCELLULAR CARCINOMA CELLS AND STEM CELLS FOR NEW THERAPEUTIC OPTIONS
E NALBAT
Middle East Technical University, 2023
2023
Vicinal Diaryl-Substituted Isoxazole and Pyrazole Derivatives with In Vitro Growth Inhibitory and In Vivo Antitumor Activity
S Turanlı, E Nalbat, D Lengerli, K Ibis, S Güntekin Ergün, ...
ACS omega 7 (41), 36206-36226, 2022
2022
Network-based in silico modeling for drug repurposing and in vitro validation in hepatocellular carcinoma
E Nalbat, N Tunçbağ, R Cetin-Atalay
15th International Symposium on Health Informatics and Bioinformatics HIBIT …, 2022
2022
Data Centric Molecular Analysis and Evaluation of Hepatocellular Carcinoma Therapeutics Using Machine Intelligence-Based Tools
R Cetin-Atalay, DC Kahraman, E Nalbat, AS Rifaioglu, A Atakan, ...
Journal of Gastrointestinal Cancer 52 (4), 1266-1276, 2021
2021
In vitro validation of drug-target interactions revealed in silico by Comprehensive Resource of Biomedical Relations with Network Representations and Deep …
E Nalbat, AS Rifaioglu, T Dogan, MJ Martin, R Cetin-Atalay, V Atalay
Cancer Research 80 (16_Supplement), 5235-5235, 2020
2020
In silico modeling and in vitro validation of undefined off-target of drugs in hepatocellular carcinoma
E Sinoplu, N Tuncbag, DC Kahraman, RC Atalay
Cancer Research 79 (13_Supplement), 996-996, 2019
2019
Development of spion-based theranostic nanocarriers for small rna delivery and cancer gene therapy
E Sinoplu
2016
Anticancer activity of novel vicinal diaryl isoxazole compounds in hepatocellular carcinoma
E Nalbat, E Akhan Güzelcan, S Turanlı, D Lengerli, B Çalışkan, E Banoğlu, ...
Identification of undefined off-targets of novel drugs and drug combinations with network-based in silico modeling and in vitro validation in hepatocellular carcinoma
E Nalbat, N Tunçbağ, R Atalay
Bazı Visinal Diaril Heterosiklik Bileşiklerin Antikanser Aktivitelerinin Araştırılması
S Turanli, E Nalbat, E Akhan Güzelcan, R Atalay, B Çalışkan, E Banoğlu
Novel isoxazole-piperazine derivatives inhibit the stemness of HCC cells
E NALBAT, K İBİŞ, B ÇALIŞKAN, E BANOĞLU, M ATALAY, R ATALAY
KARACİĞER KANSERİ KÖK HÜCRELERİ ÜZERİNDE İNHİBİTÖR ETKİYE SAHİP, POTANSİYEL ANTİKANSER AJANLAR OLARAK YENİ İZOKSAZOL-PİPERAZİN HİBRİTLERİNİN SENTEZİ VE BİYOLOJİK OLARAK …
K İbiş, E Nalbat, B Çalışkan, R Atalay, E Banoğlu
Synthesis of New Vicinal Diaryl Five-Membered Heterocyclic Compounds with Potential Anticancer Activity
S TURANLİ, D LENGERLİ, B ÇALIŞKAN, ECE AKHAN GÜZELCAN, ...
The system can't perform the operation now. Try again later.
Articles 1–20